» Articles » PMID: 25318641

Optimization of Drug-drug Interaction Alert Rules in a Pediatric Hospital's Electronic Health Record System Using a Visual Analytics Dashboard

Overview
Date 2014 Oct 17
PMID 25318641
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To develop and evaluate an electronic dashboard of hospital-wide electronic health record medication alerts for an alert fatigue reduction quality improvement project.

Methods: We used visual analytics software to develop the dashboard. We collaborated with the hospital-wide Clinical Decision Support committee to perform three interventions successively deactivating clinically irrelevant drug-drug interaction (DDI) alert rules. We analyzed the impact of the interventions on care providers' and pharmacists' alert and override rates using an interrupted time series framework with piecewise regression.

Results: We evaluated 2 391 880 medication alerts between January 31, 2011 and January 26, 2014. For pharmacists, the median alert rate prior to the first DDI deactivation was 58.74 alerts/100 orders (IQR 54.98-60.48) and 25.11 alerts/100 orders (IQR 23.45-26.57) following the three interventions (p<0.001). For providers, baseline median alert rate prior to the first round of DDI deactivation was 19.73 alerts/100 orders (IQR 18.66-20.24) and 15.11 alerts/100 orders (IQR 14.44-15.49) following the three interventions (p<0.001). In a subgroup analysis, we observed a decrease in pharmacists' override rates for DDI alerts that were not modified in the system from a median of 93.06 overrides/100 alerts (IQR 91.96-94.33) to 85.68 overrides/100 alerts (IQR 84.29-87.15, p<0.001). The medication serious safety event rate decreased during the study period, and there were no serious safety events reported in association with the deactivated alert rules.

Conclusions: An alert dashboard facilitated safe rapid-cycle reductions in alert burden that were temporally associated with lower pharmacist override rates in a subgroup of DDIs not directly affected by the interventions; meanwhile, the pharmacists' frequency of selecting the 'cancel' option increased. We hypothesize that reducing the alert burden enabled pharmacists to devote more attention to clinically relevant alerts.

Citing Articles

The influence of electronic health record design on usability and medication safety: systematic review.

Cahill M, Cleary B, Cullinan S BMC Health Serv Res. 2025; 25(1):31.

PMID: 39762805 PMC: 11705737. DOI: 10.1186/s12913-024-12060-2.


Design and Implementation of a Dashboard for Drug Interactions Mediated by Cytochromes Using a Health Care Data Warehouse in a University Hospital Center: Development Study.

Gosselin L, Maes A, Eyer K, Dahamna B, Disson F, Darmoni S JMIR Med Inform. 2024; 12:e57705.

PMID: 39607869 PMC: 11620019. DOI: 10.2196/57705.


Successfully Transitioning an Interruptive Alert into a Noninterruptive Alert for Central Line Dressing Changes in the Neonatal Intensive Care Unit.

Knake L, Asbury R, Penisten S, Meyer N, Burrel K, Davila R Appl Clin Inform. 2024; 15(5):965-969.

PMID: 39163999 PMC: 11560397. DOI: 10.1055/a-2394-4462.


Interprofessional Evaluation of a Medication Clinical Decision Support System Prior to Implementation.

Bauer J, Busse M, Kopetzky T, Seggewies C, Fromm M, Dorje F Appl Clin Inform. 2024; 15(3):637-649.

PMID: 39084615 PMC: 11290949. DOI: 10.1055/s-0044-1787184.


A Geospatial Drug Abuse Risk Assessment and Monitoring Dashboard Tailored for School Students: Development Study With Requirement Analysis and Acceptance Evaluation.

Al-Aboosi A, Sheikh Abdullah S, Ismail R, Maulud K, Nahar L, Zainol Ariffin K JMIR Hum Factors. 2024; 11:e48139.

PMID: 39078685 PMC: 11322689. DOI: 10.2196/48139.


References
1.
Jha A, LaGuette J, Seger A, Bates D . Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application. J Am Med Inform Assoc. 2008; 15(5):647-53. PMC: 2528042. DOI: 10.1197/jamia.M2634. View

2.
Kuperman G, Reichley R, Bailey T . Using commercial knowledge bases for clinical decision support: opportunities, hurdles, and recommendations. J Am Med Inform Assoc. 2006; 13(4):369-71. PMC: 1513681. DOI: 10.1197/jamia.M2055. View

3.
Ash J, Berg M, Coiera E . Some unintended consequences of information technology in health care: the nature of patient care information system-related errors. J Am Med Inform Assoc. 2003; 11(2):104-12. PMC: 353015. DOI: 10.1197/jamia.M1471. View

4.
Kumasaka N, Nakamura Y, Kamatani N . The textile plot: a new linkage disequilibrium display of multiple-single nucleotide polymorphism genotype data. PLoS One. 2010; 5(4):e10207. PMC: 2860502. DOI: 10.1371/journal.pone.0010207. View

5.
Smithburger P, Buckley M, Bejian S, Burenheide K, Kane-Gill S . A critical evaluation of clinical decision support for the detection of drug-drug interactions. Expert Opin Drug Saf. 2011; 10(6):871-82. DOI: 10.1517/14740338.2011.583916. View